Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark P Thomas

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Experimental Physiology|March 6, 2021
Resting skeletal muscle PNPLA2 (ATGL) and CPT1B are associated with peak fat oxidation rates in men and women but do not explain observed sex differencesOliver J Chrzanowski-Smith, Robert M Edinburgh, Eleanor Smith, et al.
Plos One|July 11, 2013
CD38 Structure-Based Inhibitor Design Using the N1-Cyclic Inosine 5'-Diphosphate Ribose TemplateChristelle Moreau, Qun Liu, Richard Graeff, et al.
Journal of Neurochemistry|April 20, 2007
Genomic and proteomic microglial profiling: pathways for neuroprotective inflammatory responses following nerve fragment clearance and activationJason G Glanzer, Yoshimi Enose, Tong Wang, et al.
Chemmedchem|July 16, 2010
Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activitiesPaul M Wood, L W Lawrence Woo, Jean-Robert Labrosse, et al.
Journal of Neurochemistry|November 27, 2007
Nitrated alpha-synuclein-activated microglial profiling for Parkinson's diseaseAshley D Reynolds, Jason G Glanzer, Irena Kadiu, et al.
Chemmedchem|March 6, 2014
Synthesis, anti-tubulin and antiproliferative SAR of steroidomimetic dihydroisoquinolinonesMathew P Leese, Fabrice L Jourdan, Meriel R Major, et al.
Journal of Medicinal Chemistry|February 27, 2013
Orvinols with mixed kappa/mu opioid receptor agonist activityBenjamin M Greedy, Faye Bradbury, Mark P Thomas, et al.
The Biochemical Journal|May 19, 2017
Ligand-induced activation of human TRPM2 requires the terminal ribose of ADPR and involves Arg1433 and Tyr1349Ralf Fliegert, Joanna M Watt, Anja Schöbel, et al.
Journal of Medicinal Chemistry|December 12, 2017
Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal StructureWolfgang Dohle, Fabrice L Jourdan, Grégory Menchon, et al.
Journal of Medicinal Chemistry|October 10, 2012
Fumaroylamino-4,5-epoxymorphinans and related opioids with irreversible μ opioid receptor antagonist effectsHumphrey A Moynihan, Ian Derrick, Jillian H Broadbear, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Experimental Physiology|March 6, 2021
Resting skeletal muscle PNPLA2 (ATGL) and CPT1B are associated with peak fat oxidation rates in men and women but do not explain observed sex differencesOliver J Chrzanowski-Smith, Robert M Edinburgh, Eleanor Smith, et al.
Plos One|July 11, 2013
CD38 Structure-Based Inhibitor Design Using the N1-Cyclic Inosine 5'-Diphosphate Ribose TemplateChristelle Moreau, Qun Liu, Richard Graeff, et al.
Journal of Neurochemistry|April 20, 2007
Genomic and proteomic microglial profiling: pathways for neuroprotective inflammatory responses following nerve fragment clearance and activationJason G Glanzer, Yoshimi Enose, Tong Wang, et al.
Chemmedchem|July 16, 2010
Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activitiesPaul M Wood, L W Lawrence Woo, Jean-Robert Labrosse, et al.
Journal of Neurochemistry|November 27, 2007
Nitrated alpha-synuclein-activated microglial profiling for Parkinson's diseaseAshley D Reynolds, Jason G Glanzer, Irena Kadiu, et al.
Chemmedchem|March 6, 2014
Synthesis, anti-tubulin and antiproliferative SAR of steroidomimetic dihydroisoquinolinonesMathew P Leese, Fabrice L Jourdan, Meriel R Major, et al.
Journal of Medicinal Chemistry|February 27, 2013
Orvinols with mixed kappa/mu opioid receptor agonist activityBenjamin M Greedy, Faye Bradbury, Mark P Thomas, et al.
The Biochemical Journal|May 19, 2017
Ligand-induced activation of human TRPM2 requires the terminal ribose of ADPR and involves Arg1433 and Tyr1349Ralf Fliegert, Joanna M Watt, Anja Schöbel, et al.
Journal of Medicinal Chemistry|December 12, 2017
Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal StructureWolfgang Dohle, Fabrice L Jourdan, Grégory Menchon, et al.
Journal of Medicinal Chemistry|October 10, 2012
Fumaroylamino-4,5-epoxymorphinans and related opioids with irreversible μ opioid receptor antagonist effectsHumphrey A Moynihan, Ian Derrick, Jillian H Broadbear, et al.
Pageof 6